MedTrace Logo

Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product.

NCT02157090 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-06-05

No results posted yet for this study

Summary

Recent clinical studies showed, that a hydrocolloid patch is effective, well tolerated and comparable with aciclovir cream 5 % for the treatment of HSL lesions, while affording additional benefits of wound protection, discretion and relief of social embarrassment. The aim of the actual study was the clinical assessment of the effectiveness and safety of Hansaplast® SOS Herpes Patch (HPHP) in comparison to Compeed® Herpes Vesicle Patch (CHP) in treating HSL. Both products are CE-certificated and are available at the market for medical devices.

Conditions

  • Herpes Simplex Labialis

Interventions

OTHER

Herpes Patch SOS (Hansaplast®)

OTHER

Herpes vesicle patch of Compeed®

Sponsors & Collaborators

  • Beiersdorf AG

    collaborator UNKNOWN

  • Technische Universität Dresden

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-01-31
Completion
2010-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02157090 on ClinicalTrials.gov